# Mast Cell Activation Syndrome (MCAS) comorbidities

[Source: Characterization of Mast Cell Activation Syndrome](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341697/)

* 35% [Gastroesophageal reflux disease (GERD)](../gastroesophageal-reflux-disease/)
* 29% [Hypertension](../hypertension/)
* 23% Multiple/atypical drug reactions
* 22% Abdominal pain NOS
* 21% Hysterectomy/oophorectomy
* 20% Hyperlipidemia
* 20% Cholecystectomy
* 19% Environmental allergies
* 18% Tobacco abuse
* 18% [Asthma](../asthma/)
* 17% Diabetes mellitus type 2
* 17% Hypothyroidism
* 17% Headaches
* 16% Depression
* 16% Sinusitis
* 16% Fibromyalgia
* 15% Anemia of chronic inflammation
* 15% Sleep apnea
* 15% Freq. upper resp. infections
* 15% Miscarriage
* 14% Pharyngitis and/or tonsillitis
* 14% Dysmenorrhea
* 13% Thromboembolism
* 13% Frequent and/or atypical infections
* 13% Obesity
* 13% Osteoarthritis
* 12% Anxiety and/or panic
* 12% Vertebral disease
* 12% Cardiovascular malformations
* 11% Dermatitides
* 11% [Presyncope](../presyncope/) and/or syncope
* 11% Interstitial cystitis
* 10% Chronic kidney disease
* 10% [Postural Orthostatic Tachycardia Syndrome (POTS)](../postural-orthostatic-tachycardia-syndrome/)
